Why did Verdasco neglect to renew his TUE?

Question

Accepted Answer

Verdasco's TUE Lapse Attributed to Oversight in ADHD Medication Management

Fernando Verdasco accepted a two-month voluntary doping suspension due to methylphenidate, a medication for attention deficit hyperactivity disorder (ADHD), being found in a urine sample. While diagnosed with ADHD and prescribed the medication by his doctor, Verdasco neglected to renew his Therapeutic Use Exemption (TUE) for the substance. This lapse in renewing his TUE led to the positive test result.
Diagnosis and Prescribed Medication

Verdasco, a veteran Spanish tennis player, has been diagnosed with ADHD, a condition for which he was prescribed methylphenidate. This medication was administered under the guidance of his physician. The presence of methylphenidate in his system during a test at an ATP Challenger event in Rio de Janeiro in February was the catalyst for the subsequent investigation.
Inadvertent Breach of Anti-Doping Rules

The International Tennis Integrity Agency (ITIA) acknowledged that Verdasco's violation was inadvertent and unintentional, indicating no intent to cheat. This assessment was based on his admission of the breach and the fact that the medication was prescribed following a medical diagnosis. The ITIA stated that the circumstances surrounding the case allowed for a reduction in the suspension period.
Consequences and Return to Play

As a result of the positive test and the failure to maintain a valid TUE, Verdasco accepted a voluntary two-month suspension. He has since been granted a new TUE by the World Anti-Doping Agency (WADA). Verdasco is now eligible to return to professional tennis on January 8, following the conclusion of his reduced ban.

Reading history

Hide →

This history is cleared when the page is closed.

Why did Verdasco neglect to renew his TUE?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends